ABSTRACT To determine whether cardiac transplant rejection can be detected noninvasively with indium-11l (" 'In)-labeled lymphocytes, we studied 11 dogs with thoracic heterotopic cardiac transplants without immunosuppression and five dogs with transplants treated with cyclosporine (10 mg/kg/day) and prednisone (1 mg/kg/day). All were evaluated sequentially with gamma scintigraphy after administration of 150 to 350 ,uCi of autologous "'In-lymphocytes. Technetium-99m-labeled red blood cells (1 to 3 mCi) were used for correction of radioactivity in the blood pool attributable to circulating labeled lymphocytes. Lymphocyte infiltration was quantified as the ratio of indium in the myocardium of the transplant or native heart compared with that in blood (indium excess, IE). Results were correlated with mechanical and electrical activity of allografts and with histologic findings in sequential biopsy specimens. In untreated dogs (n = 11), IE was 15.5 + 7.0 ($D) in transplanted hearts undergoing rejection and 0.4 1.1 in native hearts on the day before animals were killed (p < .01). In dogs treated with cyclosporine and prednisone (n = 5), IE was minimal in allografts during the course of immunosuppression (0.8 ± 0.4) and increased to 22.9 ± 11.1 after immunosuppression was stopped. Scintigraphic criteria of rejection (IE > 2 SD above that in native hearts) correlated with results of biopsies indicative of rejection and appeared before electrophysiologic or mechanical manifestations of dysfunction. Thus infiltration of labeled lymphocytes in allografts, indicative of rejection, is detectable noninvasively by gamma scintigraphy and provides a sensitive approach potentially applicable to clinical monitoring for early detection of rejection and guidance for titration of immunosuppressive measures. Circulation 75, No. 4, 86&876, 1987. CARDIAC TRANSPLANTATION is an increasingly important treatment for end-stage cardiac disease, but rejection continues to be a major complication. Criteria for the presence of rejection fever, atrial arrhythmia, alterations in QRS voltage, leukocytosis, and impaired ventricular performance -are insensitive and nonspecific. Thus serial endomyocardial biopsy is required for monitoring patients. Although relatively Received Sept. 12, 1986; revision accepted Jan. 14, 1987. *All editorial decisions for this article, including selection of reviewers and the final disposition, were made by a guest editor. This procedure applies to all manuscripts with authors from the Washington Uni- 
safe,' biopsy is an invasive and expensive approach to detecting rejection.
Infiltration of lymphocytes is a feature of early rejection.2" We and others have demonstrated the feasibility of detecting early rejection of heterotopic transplants in small laboratory animals with indium- 11 ("'In) -labeled lymphocytes.`8 Detection of rejection with "'In-leukocytes has also been attempted in patients.9 However, the suitability of this approach for potential clinical applications has not been established. The present study was performed to determine whether rejection of heterotopic cardiac transplants in large animals under conditions simulating those encountered clinically could be detected sensitively and reliably. Erythrocytes labeled with technetium-99m (99Tc) were used as a blood pool tracer for compensation by subtraction of radioactivity attributable to circulating lymphocytes. The subtraction technique is analogous to one developed in our laboratory for the scintigraphic identification of coronary artery thrombi.i0`Each dog was used as its own control with correlative assessments of scintigrams and histopathologic studies in the native and transplanted hearts. Some dogs were treated with immunosuppressive agents to define the utility of scintigraphy for detecting effects of treatment. Methods
Animals. Sixteen mongrel dogs were subjected to chest heterotopic cardiac transplantation.'2 They were anesthetized with sodium pentothal and intubated. Ventilation was maintained with a Harvard respirator. Anesthesia was maintained with enflurane (Ohio Medical Products). Donor hearts harvested from unmatched mongrel dogs were arrested with hyperkalemic cardioplegic solution and placed in the recipient's chest via a left thoracotomy. The donor aorta was anastomosed to the recipient subclavian artery and the donor pulmonic artery to the recipient superior vena cava in an end-to-side fashion. Thus circulation to the allograft was retrograde, perfusing only the grafts via their coronary circulation. The allografts did not support the recipient's circulation. Experimental protocol. Eleven dogs were given prednisone perioperatively without other immunosuppressive agents. Spontaneous rejection of the allografts occurred in each. Electrocardiograms with six limb leads and fluoroscopic assessments of allograft function were obtained daily. Lymphocytes were labeled 3 days after transplantation. Scintigraphy was performed daily beginning 24 hr after administration of labeled lymphocytes and continued until mechanical activity of the allograft ceased. Lymphocytes were labeled approximately every 3 to 4 days so that acquisition of counts would be sufflcient (tl/2 of "'In = 67 hr). Right ventricular endomyocardial biopsies were performed transvenously under fluoroscopic guidance every 3 days with a cardiac bioptome (Cordis).
Five other animals with transplants were subjected to an immunosuppressive regimen for 2 weeks consisting of oral administration of cyclosporine (10 mg/kg/day) and prednisone (1 mg/kg/day). After (Coming) and centrifuged (IEC Centra 7-R) at 360 g at 25°C for 30 min. The lymphocyte layer was removed and washed twice in 50 ml polycarbonate centrifuge tubes (Sorvall) with 0.9% NaCl-ACD (7: 1, vol/vol) by centrifugation at 600 g at 250 C for 10 min (Sorvall RC-5 centrifuge). The resulting pellet was diluted with 1 ml of platelet-free plasma and 2 ml of NaCl-ACD, layered onto 8 ml Ficoll-Paque in 15 ml polystyrene centrifuge tubes (Coming), and centrifuged at 360 g for 30 min. The lymphocyte layer was then washed twice in NaCl-ACD at 600 g for 10 min followed by a wash in 1 ml platelet-free plasma and one in NaCl-ACD at 600 g for 10 min. Recovery of lymphocytes in the final cell pellet averaged 57 + 12% (mean ± SD). The second Ficoll-Paque centrifugation was used to reduce contamination to less than four platelets per lymphocyte in the final preparation.
The final cell pellet, containing 2 to 5 x 108 cells, was suspended in 1.0 ml of NaCl-ACD. One hundred fifty to 300 gCi "'In-oxine (Amersham) (containing a maximum of 2.4 mg of HEPES buffer and 20 ,ug of oxine per dose) was added slowly to the suspension, incubated at room temperature for 20 min, and centrifuged at 600 g for 10 min. To remove unbound "'Inoxine, labeled cells were washed twice in 1 ml of platelet-free plasma at 600 g for 10 min in a Dynac II centrifuge. Efficiency of labeling, determined by counting radioactivity in 2 ,l aliquots of the initial and final suspension and in all resulting supernatants in a gamma-well counter (LKB-Wallace, Model 1282), was 45% to 85%. The cells were suspended in 2 ml of NaCl-ACD and injected intravenously. Viability, as assessed by the nigrosin exclusion test, was 97%.
To determine whether the indium label remained associated with circulating lymphocytes in vivo, 24 hr after administration of labeled lymphocytes, 2 ml of whole blood were obtained and centrifuged at 600 g for 5 min to separate platelet-rich plasma (PRP) from lymphocytes and other cellular elements. The PRP was centrifuged at 3000 g for 15 min to separate platelets from plasma. Aliquots of whole blood, PRP, and platelet-poor plasma were assayed for radioactivity in a gamma-well counter. A total of 80% to 95% of radioactivity was recovered in the cellular fraction, 2% to 5% in plasma (as indium-transferrin), and 5% to 12% in platelets (correcting for platelets/mm3 in PRP compared with whole blood).
Labeling of erythrocytes with '91Tc. To permit subtraction of radioactivity attributable to labeled lymphocytes circulating in the blood pool, we employed a subtraction technique with 99mTc-labeled red blood cells. For labeling, 2 ml of whole blood were obtained and anticoagulated with ACD. The blood was centrifuged at 1800 g for 2 min. The supernatant fraction was removed, and the cells were washed once with 0.9% NaCl at 1800 g at 22°C for 2 min. The erythrocytes were incubated with 50 gg of stannous glucoheptonate for 5 min followed by an NaCl wash and then incubated with 3 to 4 mCi of 99mTc pertechnitate at 220 C for 5 min. The cells were washed and resuspended in 2 ml NaCl. Efficiency of labeling was 80% to 95%. 99ITc-labeled erythrocytes were administered intravenously after acquisition of data with "'In.
Histology and postmortem well counting. Biopsy and postmortem samples were fixed in sodium phosphate-buffered 10% formalin. Samples were stained with hematoxylin and eosin for histologic assessment by an investigator blinded to scintigraphic data and treatment regimen. Histologic grading was performed according to the Billingham classification.13 Radioactivity in postmortem specimens of native and transplant hearts and blood was assayed in a gamma-well counter after the specimen had been weighed and fixed in formalin.
Autoradiography. To confirm that infiltration of radioactivity into allografts was associated with labeled lymphocytes, autoradiographs were prepared from frozen sections of myocardium from an untreated allograft recipient. Sections were applied to gelatin-coated slides, dipped into Kodak nuclear track emulsion (type NTB-3, 1:1 dilution in water) at 320 C, and withdrawn at a constant rate of 120 mm/min. The slides were ( 
Results
Sixteen heterotopic transplants were successful. Postmortem analysis was performed as soon as possible after cessation of mechanical activity of the rejecting allograft was detectable fluoroscopically. The 11 recipients not treated with immunosuppression were killed a mean of 10 + 4 days after surgery (range 6 to 18) ( figure 1, A) . Five dogs were treated with cyclosporine (10 mg/kg/day) and prednisone (1 mg/kg/day) for 2 weeks after transplantation. Mean survival of the allografts in this group was 26 ± 12 days ( figure 1, B) .
All initially successful heterotopic transplants exhibited normal sinus rhythm 1 day after operation. Rejecting hearts manifested progressive bradycardia, decreased QRS voltage, and widening of the QRS complex. No electrophysiologic evidence of rejection was noted in hearts from dogs being treated with immunosuppressive agents.
Accumulation of radioactivity in untreated allografts.
Scintigrams obtained after administration of '`"In-lymphocytes and 99Tc-labeled red blood cells and after correction for circulating lymphocyte activity from a dog in the untreated group are shown in figure 2. Four days after transplantation, no uptake of "'In-lymphocytes was noted in either the allograft or the native heart. Two days later, uptake was observed in the rejecting allograft. With correction for radioactivity associated with lymphocytes circulating in the blood pool, uptake of`In-lymphocytes in the allograft was accentuated.
"'In accumulation in allografts increased with time after transplantation in all untreated dogs as shown in figure 3 . No significant accumulation was evident in the native hearts ( figure 3 and table 1) .
Effect of immunosuppression on accumulation of 111In-lymphocytes in transplanted hearts. "'In scintigrams, 99mTc scintigrams, and blood pool-corrected scintigrams obtained 24 hr after injection of "l'In-lymphocytes from a dog treated with cyclosporine and prednisone for 12 days and in the same animal 5 days later (2 days after cessation of immunosuppression) are shown in allograft occurred when immunosuppression was stopped.
Accumulation of 1`1In activity during and after cessation of immunosuppression in all dogs in the treated group is summarized in figure 5 and table 2. Accumulation of lymphocytes in the allografts did not occur during immunosuppression but was progressive after its cessation. No significant uptake of`in occurred in native hearts. Identification of rejection by scintigraphy. Scintigraphic evidence of rejection (defined as an IE > 2 SD above that in native hearts, i.e., > 2.6) was compared with histologic degree of rejection. Seventeen episodes of rejection were documented by endomyocardial biopsy. Of four mild episodes of rejection, three were correctly identified scintigraphically. Seven episodes of moderate rejection and six episodes of severe rejection were documented by endomyocardial biopsy and all of these were correctly identified scintigraphically. For all 18 histologically normal biopsy specimens, concurrent scintigrams were read as normal. Three specimens were read as equivocal. One of the hearts from which they came exhibited scintigraphic evidence of rejection.
Vol. 75 The extent of uptake of 'In assayed postmortem by well counting is shown in table 3. High ratios of radioactivity in transplant compared with native hearts with respect to radioactivity in blood were evident.
Autoradiography. Autoradiographs from a cardiac allograft obtained 7 days after transplantation from an untreated dog demonstrated that accumulation of radioactivity was attributable to labeled lymphocytes (figure 6).
Discussion
Results of this study indicate that "'In-lymphocytes accumulate in rejecting cardiac allografts progressively and that the uptake is readily detectable by sequential gamma scintigraphy. Subtraction of radioactivity associated with labeled, circulating lymphocytes with the use of 99mTc-labeled red blood cells permitted assessment of infiltration of allografts with labeled lymphocytes. Immunosuppression prevented both rejection and infiltration of labeled lymphocytes reflected scintigraphically. Cessation of immunosuppression elicited rejection detectable scintigraphically by increases in uptake of "1 In-lymphocytes in allografts and confirmed histologically.
The mean IE in native control hearts was 0.4 ±+ l. 1 (range 0 to 3.7). An IE over 3.7 did not occur in any native heart or in allografts during immunosuppression. Allografts with an IE greater than 4.0 exhibited rejection histologically. Only one exception occurred with a biopsy interpreted as "equivocal" from a heart with an IE of 5. Biopsies performed shortly after transplantation may reveal evidence of ischemia-induced reperfusion injury. Histologically this is manifested by subendocardial leukocytic infiltration. Scintigraphically, it may be difficult to differentiate from rejection in the early postoperative period, although several factors may help in distinguishing the two processes. These include the nature of the cellular infiltrate, the time course of reperfusion injuiry compared with cell-mediated rejection (the former occurs within the first 48 hr after surgery while the rejection occurs later), and the histologic distribution of the cellular infiltrate (subendocardial in ischemia vs diffuse in rejection). Transplant patients may also develop opportunistic infections that may involve the myocardium, most often due to toxoplasmosis or cytomegalovirus, in which lymphocytic infiltration is frequently evident histologically. 15 Scintigraphy with labeled lymphocytes may not be able to distinguish these syndromes from acute rejection. Endomyocardial biopsy would be required to assist in diagnosing these infections, although the characteristic histologic features of toxoplasmosis (cysts) or cytomegalovirus (giant cells with inclusion bodies) may be absent. Supplemental clinical data such as serologic tests, virus isolation from cultures of buffy coat and urine, and evidence of systemic disease are often required to confirm these diagnoses.t6M ononuclear cell infiltration can be present in histologic specimens of nonrejecting allografts in cyclosporine-treated patients. This has been raised as a potential drawback for using labeled lymphocytes to detect rejection. 8 Data expressed as mean + SD (and ranges) of IE in transplanted hearts and native hearts in dogs treated with cyclosporine and prednisone for 14 days. After cessation of immunosuppression, a progressive increase of IE in the allografts occurred, reaching a maximum 1 day before death (n = 4).
Ap < .01.
BOnly one animal in the group survived more than 7 days after immunosuppression was stopped.
874 CIRCULATION 25r Comparison of ratios of radioactivity in samples of transplant left and right ventricle (LV and RV) with that in native LV and RV and radioactivity in transplant LV, transplant RV, native LV, and native RV with that in blood (n -15).
tivity to the spleen, liver, and bone marrow associated with administration of "'In-lymphocytes to be 9.0, 1.5, and 0.95 rads/500 gCi, respectively. This compares favorably to the marrow dose of radioactivity in patients treated conventionally for hyperthyroidism with iodine-131 (13 rads).`o In such patients, no increased incidence of leukemia has been detected. The present results indicate that`I n-lymphocyte scintigraphy with blood pool subtraction may provide a sensitive and relatively specific method for noninvasive detection of acute cardiac allograft rejection. This technique merits further evaluation, including assessment of its utility in patients. The approach developed may be particularly helpful for ascertaining the need for and timing of endomyocardial biopsy in individual patients and for monitoring the response of rejection to immunosuppressive drugs.
